Diagnostic agent

Claim 2

In the known diagnostic agent for intravascular administration into blood vessels composed of 5 - labelled particles suspended in a physiologically acceptable aqueous liquid, said particles having a size so selected that they clog fine blood vessels having a diameter within the range 5-300 μm, the improvement which comprises said particles consisting of a three-dimensional, water-insoluble, hydrophilic, swellable, cross-linked network of polysaccharide substances, said network being composed of a polysaccharide substance selected from the group consisting of starch, amylose, amylopectin, glycogen, and dextrin, cross-linking having been effected by ether bonds that form bridges between polysaccharide substances, said bridges being straight or branched aliphatic saturated hydrocarbon chains substituted with one to six hydroxyl group and containing 3 - 20 carbon atoms and being unbroken or broken with one to six oxygen atoms, the total substitution degree for the polysaccharide being lower than 70% and higher than 5%, said substitution degree being given as the percentage of the number of substituted glucose units with respect to the total number of glucose units present, said three-dimensional network being degradable by the α-amylase in blood plasma into water-soluble fragments and said cross-linked polysaccharide substance swelling to a gel in the presence of water, said gel containing more than 50% and less than 99.5% by weight of water.

Claim 3

An agent according to claim 1, wherein the total substitution degree for the polysaccharide is lower than 60% and higher than 10% , said substitution degree being given as the percentage of the number of substituted glucose units with respect to the total number of glucose units present.

Claim 4

In the known diagnostic agent for intravascular administration into blood vessels composed of radioactively labelled particles suspended in a physiologically acceptable aqueous liquid, said particles having a size so selected that they clog fine blood vessels having a diameter within the range 5 - 300 μm the improvement which comprises said particles consisting of a three-dimensional, water-insoluble hydrophilic, swellable, cross-linked network of polysaccharide substances, said network being composed of a polysaccharide substance selected from the group consisting of starch, amylose, amylopectin, glycogen, dextrin, or a physiologically acceptable derivative of one of the aforesaid polysaccharides cross-linking having been effected by ether bonds that form bridges between polysaccharide substances, said bridges being straight or branched aliphatic saturated hydrocarbon chains substituted with one to six hydroxyl groups and containing 3 - 20 carbon atoms and being unbroken or broken with one to six oxygen atoms, the total substitution degree for the polysaccharide being lower than 70% and higher than 5%, said substitution degree being given as the percentage of the number of substituted glucose units with respect to the total number of glucose units present, said three-dimensional network being degradable by the α-amylase in blood plasma into water-soluble fragments and said cross-linked polysaccharide substance swelling to a gel in the presence of water, said gel containing more than 50% and less than 99.5% by weight of water.

Claim 5

In the known diagnostic agent for intravascular administration into blood vessels composed of radioactively labelled particles suspended in a physiologically acceptable aqueous liquid, said particles having a size so selected that they clog fine blood vessels having a diameter within the range 5 - 300 μm the improvement which comprises said particles consisting of a three-dimensional, water-insoluble hydrophilic, swellable, cross-linked network of polysaccharide substances, said network being composed of a polysaccharide substance selected from the group consisting of starch, amylose, amylopectin, glycogen, dextrin, or a physiologically acceptable derivative of one of the aforesaid polysaccharides cross-linking having been effected by ether bonds that form bridges between polysaccharide substances, said bridges being straight or branched aliphatic saturated hydrocarbon chains substituted with one to six hydroxyl groups and containing 3 - 20 carbon atoms and being unbroken or broken with one to six oxygen atoms, the total substitution degree for the polysaccharide being lower than 70% and higher than 5%, said substitution degree being given as the percentage of the number of substituted glucose units with respect to the total number of glucose units present, said three-dimensional network being degradable by the α-amylase in blood plasma into water-soluble fragments and said cross-linked polysaccharide substance swelling to a gel in the presence of water, said gel containing more than 50% and less than 99.5% by weight of water.

Claim 6

An agent according to claim 3, wherein said polysaccharide derivatives contain as substitutents at least one member selected from the group consisting of 2-hydroxyethyl, 2-hydroxypropyl, 2,3-dihydroxypropyl, acetyl, propionyl, 2-hydroxypropanoyl, succinoyl and glutaroyl.

Claim 7

An agent according to claim 3 wherein the total substitution degree for the polysaccharide is lower than 60% and higher than 10%, said substitution degree being given as the percentage of the number of substituted glucose units with respect to the total number of glucose units present.

Claim 8

An agent according to claim 3, wherein said cross-linked polysaccharide substance swells to a gel in the presence of water, said gel containing more than 65% and less than 98% by weight of water.

Claim 9

An agent according to claim 3, wherein the meshes of said three-dimensional network have a size such that protein molecules of the same size as α-amylase are able to penetrate into the particles in their water-swollen state.

Claim 10

An agent according to claim 3 wherein the outer layer of said three-dimensional network is degraded more slowly by α-amylase than the central portion of said network.

Claim 11

An agent according to claim 3 wherein said particles are substantially spherical in shape.

Claim 12

An agent according to claim 3, wherein said particles have a size of 5 - 60 μm in their water-swollen state.

Claim 13

An agent according to claim 3 wherein said three-dimensional network can be degraded by α-amylase into water-soluble fragments having a molecular weight beneath 50,000.

Claim 14

An agent according to claim 3 wherein said particles are labelled with a radioactive isotope of technetium.

Claim 15

In the known method of effecting a diagnosis with the aid of radioactive substance, in which method there is intravascularly administered into blood vessels a diagnostic agent composed of radioactively labelled particles suspended in a physiologically acceptable aqueous liquid, said particles having a size so selected that they clog fine blood vessels having a diameter within the range 5 - 300 μm and then measuring the radioactive radiation over the relevant portion of the body, the improvement which comprises using particles consisting of a three-dimensional, water-insoluble, hydrophilic, swellable, cross-linked network of polysaccharide substances, said network being composed of a polysaccharide substance selected from the group consisting of starch, amylose, amylopectin, glycogen and dextrin, cross-linking having been effected by ether bonds that form bridges between polysaccharide substances, said bridges being straight or branched aliphatic saturated hydrocarbon chains substituted with one to six hydroxyl groups and containing 3 - 20 carbon atoms and being unbroken or broken with one to six oxygen atoms, the total substitution degree for the polysaccharide being lower than 70% and higher than 5%, said substitution degree being given as the percentage of the number of substituted glucose units with respect to the total number of glucose units present, said three-dimensional network being degradable by the α-amylase in blood plasma into water-soluble fragments and said cross-linked polysaccharide substance swelling to a gel in the presence of water, said gel containing more than 50% and less than 99.5% by weight of water.

Claim 16

In the known method of effecting a diagnosis with the aid of radioactive substance, in which method there is intravascularly administered into blood vessels a diagnostic agent composed of radioactively labelled particles suspended in a physiologically acceptable aqueous liquid, said particles having a size so selected that they clog fine blood vessels having a diameter within the range 5 - 300 μm and then measuring the radioactive radiation over the relevant portion of the body, the improvement which comprises using particles consisting of a three-dimensional, water-insoluble, hydrophilic, swellable, cross-linked network of polysaccharide substances, said network being composed of a polysaccharide substance selected from the group consisting of starch, amylose, amylopectin, glycogen and dextrin, cross-linking having been effected by ether bonds that form bridges between polysaccharide substances, said bridges being straight or branched aliphatic saturated hydrocarbon chains substituted with one to six hydroxyl groups and containing 3 - 20 carbon atoms and being unbroken or broken with one to six oxygen atoms, the total substitution degree for the polysaccharide being lower than 70% and higher than 5%, said substitution degree being given as the percentage of the number of substituted glucose units with respect to the total number of glucose units present, said three-dimensional network being degradable by the α-amylase in blood plasma into water-soluble fragments and said cross-linked polysaccharide substance swelling to a gel in the presence of water, said gel containing more than 50% and less than 99.5% by weight of water.

Claim 17

In the known method of effecting a diagnosis with the aid of radioactive substance, in which method there is intravascularly administered into blood vessels a diagnostic agent composed of radioactively labelled particles suspended in a physiologically acceptable aqueous liquid, said particles having a size so selected that they clog fine blood vessels having a diameter within the range 5 - 300 μm and then measuring the radioactive radiation over the relevant portion of the body, the improvement which comprises using particles consisting of a three-dimensional, water-insoluble, hydrophilic, swellable, cross-linked network of polysaccharide substances, said network being composed of a polysaccharide substance selected from the group consisting of starch, amylose, amylopectin, glycogen, dextrin, or a physiologically acceptable derivative of one of the aforesaid polysaccharides, cross-linking having been effected by ether bonds that form bridges between polysaccharide substances, said bridges being straight or branched aliphatic saturated hydrocarbon chains substituted with one to six hydroxyl groups and containing 3 - 20 carbon atoms and being unbroken or broken with 1 to 6 oxygen atoms, the total substitution degree for the polysaccharide being lower than 70% and higher than 5%, said substitution degree being given as the percentage of the number of substituted glucose units with respect to the total number of glucose units present, said three-dimensional network being degradable by the α-amylase in blood plasma, into water-soluble fragments and said cross-linked polysaccharide substance swelling to a gel in the presence of water, said gel containing more than 50% and less than 99.5% by weight of water.

Claim 18

In the known method of effecting a diagnosis with the aid of radioactive substance, in which method there is intravascularly administered into blood vessels a diagnostic agent composed of radioactively labelled particles suspended in a physiologically acceptable aqueous liquid, said particles having a size so selected that they clog fine blood vessels having a diameter within the range 5 - 300 μm and then measuring the radioactive radiation over the relevant portion of the body, the improvement which comprises using particles consisting of a three-dimensional, water-insoluble, hydrophilic, swellable, cross-linked network of polysaccharide substances, said network being composed of a polysaccharide substance selected from the group consisting of starch, amylose, amylopectin, glycogen, dextrin, or a physiologically acceptable derivative of one of the aforesaid polysaccharides, cross-linking having been effected by ether bonds that form bridges between polysaccharide substances, said bridges being straight or branched aliphatic saturated hydrocarbon chains substituted with one to six hydroxyl groups and containing 3 - 20 carbon atoms and being unbroken or broken with 1 to 6 oxygen atoms, the total substitution degree for the polysaccharide being lower than 70% and higher than 5%, said substitution degree being given as the percentage of the number of substituted glucose units with respect to the total number of glucose units present, said three-dimensional network being degradable by the α-amylase in blood plasma, into water-soluble fragments and said cross-linked polysaccharide substance swelling to a gel in the presence of water, said gel containing more than 50% and less than 99.5% by weight of water.